IL145675A0 - Vascular endothelial cell growth factor variants and uses thereof - Google Patents

Vascular endothelial cell growth factor variants and uses thereof

Info

Publication number
IL145675A0
IL145675A0 IL14567500A IL14567500A IL145675A0 IL 145675 A0 IL145675 A0 IL 145675A0 IL 14567500 A IL14567500 A IL 14567500A IL 14567500 A IL14567500 A IL 14567500A IL 145675 A0 IL145675 A0 IL 145675A0
Authority
IL
Israel
Prior art keywords
growth factor
cell growth
vascular endothelial
endothelial cell
factor variants
Prior art date
Application number
IL14567500A
Other languages
English (en)
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of IL145675A0 publication Critical patent/IL145675A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/009—Sachets, pouches characterised by the material or function of the envelope
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL14567500A 1999-04-16 2000-04-10 Vascular endothelial cell growth factor variants and uses thereof IL145675A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12978899P 1999-04-16 1999-04-16
US18423500P 2000-02-23 2000-02-23
PCT/US2000/009483 WO2000063380A1 (en) 1999-04-16 2000-04-10 Vascular endothelial cell growth factor variants and uses thereof

Publications (1)

Publication Number Publication Date
IL145675A0 true IL145675A0 (en) 2002-06-30

Family

ID=26827914

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14567500A IL145675A0 (en) 1999-04-16 2000-04-10 Vascular endothelial cell growth factor variants and uses thereof
IL145675A IL145675A (en) 1999-04-16 2001-09-25 Vascular endothelial cell growth factor variants and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL145675A IL145675A (en) 1999-04-16 2001-09-25 Vascular endothelial cell growth factor variants and uses thereof

Country Status (15)

Country Link
US (1) US20060063203A1 (enExample)
EP (2) EP1655368B1 (enExample)
JP (1) JP2002541849A (enExample)
KR (1) KR100634926B1 (enExample)
CN (1) CN1328376C (enExample)
AT (2) ATE420177T1 (enExample)
AU (1) AU771042B2 (enExample)
CA (1) CA2370246C (enExample)
DE (2) DE60041367D1 (enExample)
ES (2) ES2265931T3 (enExample)
HU (1) HU228898B1 (enExample)
IL (2) IL145675A0 (enExample)
MX (1) MXPA01010469A (enExample)
NZ (1) NZ514488A (enExample)
WO (1) WO2000063380A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020473A (en) * 1995-08-25 2000-02-01 Genentech, Inc. Nucleic acids encoding variants of vascular endothelial cell growth factor
WO2001032695A2 (en) * 1999-11-02 2001-05-10 Genentech, Inc. MODULATION OF eNOS ACTIVITY AND THERAPEUTIC USES THEREOF
US7078382B1 (en) 1999-11-02 2006-07-18 Genentech, Inc. Modulation of eNOS activity and therapeutic uses thereof
US20050123925A1 (en) 2002-11-15 2005-06-09 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
EP1572724A4 (en) * 2002-03-01 2007-03-14 Dyax Corp KDR AND VEGF / KDR BINDING SPEPTIDES AND THEIR USE IN DIAGNOSIS AND THERAPY
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
AU2003228276B8 (en) 2002-03-01 2010-02-18 Bracco Suisse S.A. Multivalent constructs for therapeutic and diagnostic applications
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7211240B2 (en) * 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
WO2004065621A1 (en) 2002-03-01 2004-08-05 Dyax Corp. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
WO2003103581A2 (en) 2002-06-05 2003-12-18 Genentech, Inc. Compositions and methods for liver growth and liver protection
US7696320B2 (en) 2004-08-24 2010-04-13 Domantis Limited Ligands that have binding specificity for VEGF and/or EGFR and methods of use therefor
US7632810B2 (en) 2003-03-12 2009-12-15 Genentech, Inc. Compositions with hematopoietic and immune activity
ATE456579T1 (de) 2004-07-20 2010-02-15 Genentech Inc Angiopoietin-like 4 protein hemmer kombinationen und deren verwendung
NZ552957A (en) 2004-07-20 2011-06-30 Genentech Inc Compositions and methods of using angiopoietin-like 4 protein
PL1861116T3 (pl) 2005-03-25 2016-02-29 Regeneron Pharma Formulacje antagonistów VEGF
WO2007109183A2 (en) * 2006-03-20 2007-09-27 Novartis Ag Mutations and polymorphisms of fms-related tyrosine kinase 1
US7608261B2 (en) 2006-06-16 2009-10-27 Regeneron Pharmacuticals, Inc. VEGF antagonist formulations suitable for intravitreal administration

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US169292A (en) * 1875-10-26 Improvement in butter-packages
DK0751992T3 (da) * 1994-03-08 2006-03-06 Human Genome Sciences Inc Karendotelvækstfaktor 2
CN1185159A (zh) * 1995-06-06 1998-06-17 人体基因组科学有限公司 人血管内皮生长因子3
US6020473A (en) * 1995-08-25 2000-02-01 Genentech, Inc. Nucleic acids encoding variants of vascular endothelial cell growth factor
US6750044B1 (en) * 1996-10-17 2004-06-15 Genentech, Inc. Variants of vascular endothelial cell growth factor having antagonistic properties, nucleic acids encoding the same and host cells comprising those nucleic acids

Also Published As

Publication number Publication date
AU4222000A (en) 2000-11-02
KR100634926B1 (ko) 2006-10-17
ATE420177T1 (de) 2009-01-15
CA2370246A1 (en) 2000-10-26
WO2000063380A1 (en) 2000-10-26
EP1655368A1 (en) 2006-05-10
EP1171594B1 (en) 2006-06-07
MXPA01010469A (es) 2002-07-30
CN1352684A (zh) 2002-06-05
KR20020008151A (ko) 2002-01-29
DE60028565D1 (de) 2006-07-20
HUP0200827A2 (en) 2002-06-29
IL145675A (en) 2010-11-30
CN1328376C (zh) 2007-07-25
ATE329024T1 (de) 2006-06-15
ES2320367T3 (es) 2009-05-21
CA2370246C (en) 2017-03-21
US20060063203A1 (en) 2006-03-23
DE60041367D1 (de) 2009-02-26
AU771042B2 (en) 2004-03-11
ES2265931T3 (es) 2007-03-01
JP2002541849A (ja) 2002-12-10
HK1093218A1 (en) 2007-02-23
EP1171594A1 (en) 2002-01-16
EP1655368B1 (en) 2009-01-07
HUP0200827A3 (en) 2004-11-29
HU228898B1 (en) 2013-06-28
NZ514488A (en) 2004-01-30
DE60028565T2 (de) 2007-06-06

Similar Documents

Publication Publication Date Title
IL145675A (en) Vascular endothelial cell growth factor variants and uses thereof
ATE314395T1 (de) Humanisierte antikörper und verfahren zu ihrer herstellung
DE3851153D1 (de) Genetische modifizierung von endothelialen zellen.
WO2000037502A3 (en) Vascular endothelial cell growth factor antagonists and uses thereof
BG103232A (en) Heterocyclic esters and amides
DK0939767T3 (da) Procin faktor VIII og hybrider deraf
LU91320I9 (enExample)
DK1129186T3 (da) Et faktor VIII-polypeptid med faktor VIII:C-aktivitet
MX9604402A (es) Proteina similar a albumina serica humana.
EP0795605A4 (en) DENAHRED LOW-DENSITY LIPOPROTEIN (LDL) RECEPTOR
EP1109454A4 (en) NEISSERIA MENINGITIDIS POLYPEPTID, NUCLEIC ACID SEQUENCE AND USES THEREOF
EP1204672A4 (en) LIGANDS AND NUCLEIC ACID INHIBITORS OF GROWTH FACTOR RECEPTOR WITH HIGH ENDOTHELIAL VASCULAR AFFINITY (VEGF)
ZA981339B (en) Transgenic animal with recombinant vascular endothelial growth factor B (vegf-b) dna and uses thereof
ATE221204T1 (de) Rezeptorbindungsassay, für den rezeptorbindungsassay geeigneter rekombinanter fusionsrezeptor, vektor zu dessen herstellung sowie reagenziensatz für die durchführung des rezeptorbindungsassays
Kabziński et al. Sepharose-DTNB covalent affinity chromatography of hepatic metallothionein from Cu-treated rats
WO1996018735A3 (en) Tgf-beta superfamily type ii receptor having binding affinity for bone morphogenic protein (bmp)
WO2001021794A3 (en) Smad associating polypeptides